Form D · Biotechnology

InGeneron, Inc.

Houston, TX · CIK 0001678766

Offering snapshot reported Mar 4, 2024 · SEC filing

Reported sold
$1.75M
Offering amount: $1.75M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 16, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 4, 2024Initial$1,749,181No comparison10SEC filing
Apr 18, 2019Initial$3,500,000No comparison1SEC filing
Mar 6, 2017Initial$9,867,575No comparison4SEC filing
Dec 20, 2016Initial$2,150,000No comparison4SEC filing
Jul 7, 2016Initial$4,500,005No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-506557

Source: Form D, filed Mar 4, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fabian Alt Director, Executive
Eckhard Alt Director, Executive
Eckhard Alt, M.D., Ph.D Director
Eckhard U. Alt, M.D., Ph.D. Director
Michael Coleman Executive
Bobby Griffin Director
Jerry Griffin Director
Jerry Griffin, M.D. Director
Bobby Griffin, Ms Director
Klaus Keller Director
Kelby Krabbenhoft Director
Amber Langner Director
Angelo Moesslang Executive
Ron Stubbers Executive
Annette White Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
8205 El Rio
Houston, TX, 77054